3-HYDROXYOXINDOLE DERIVATIVES AS CRHR2 ANTAGONIST

The present invention relates to 3-hydroxyoxindole derivatives which have antagonistic activities against CRHR2, and which are useful in the treatment or prevention of disorders and diseases in which CRHR2 is involved. The invention also relates to pharmaceutical compositions comprising these compou...

Full description

Saved in:
Bibliographic Details
Main Authors ANDO, Kazuo, MAGARA, Ryohei, OHMI, Masashi
Format Patent
LanguageEnglish
Published 18.01.2024
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present invention relates to 3-hydroxyoxindole derivatives which have antagonistic activities against CRHR2, and which are useful in the treatment or prevention of disorders and diseases in which CRHR2 is involved. The invention also relates to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CRHR2 is involved.
AbstractList The present invention relates to 3-hydroxyoxindole derivatives which have antagonistic activities against CRHR2, and which are useful in the treatment or prevention of disorders and diseases in which CRHR2 is involved. The invention also relates to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CRHR2 is involved.
Author OHMI, Masashi
MAGARA, Ryohei
ANDO, Kazuo
Author_xml – fullname: ANDO, Kazuo
– fullname: MAGARA, Ryohei
– fullname: OHMI, Masashi
BookMark eNrjYmDJy89L5WQwNNb1iHQJ8o-I9I_w9HPx93FVcHEN8gxzDPEMcw1WcAxWcA7yCDJScPQLcXT39_MMDuFhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfGhwUYGRiYGhhaGBsaOhsbEqQIAB80pYA
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US2024018103A1
GroupedDBID EVB
ID FETCH-epo_espacenet_US2024018103A13
IEDL.DBID EVB
IngestDate Fri Oct 25 05:44:03 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US2024018103A13
Notes Application Number: US202118028062
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240118&DB=EPODOC&CC=US&NR=2024018103A1
ParticipantIDs epo_espacenet_US2024018103A1
PublicationCentury 2000
PublicationDate 20240118
PublicationDateYYYYMMDD 2024-01-18
PublicationDate_xml – month: 01
  year: 2024
  text: 20240118
  day: 18
PublicationDecade 2020
PublicationYear 2024
RelatedCompanies RaQualia Pharma Inc
RelatedCompanies_xml – name: RaQualia Pharma Inc
Score 3.511194
Snippet The present invention relates to 3-hydroxyoxindole derivatives which have antagonistic activities against CRHR2, and which are useful in the treatment or...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Title 3-HYDROXYOXINDOLE DERIVATIVES AS CRHR2 ANTAGONIST
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240118&DB=EPODOC&locale=&CC=US&NR=2024018103A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1dS8Mw8BhT1DeditMpBaVvxXX9fijSNa2tuHb0i-5prCUFQbrhKv59L6XTPe0tycEluXC5j9xdAJ4mJSsjt8ITmBSFIKvUEAyqVQITpWOjUlXaFnueBaqXym-5kvfgc5cL09YJ_WmLIyJHlcjvTXtfb_6dWKSNrdw-Fx84tH5xE5PwnXWM4gkVZp5MTWcektDmbdtMYz6IOpgujiULbaUjVKQ1FgDmZFOWl7LZFyruORzPEV_dXECP1gM4tXd_rw3gZNY9eWOz477tJYiS4C1IFOaLMPcDEr47HEE7LLMSP3Nizoo5O_KiCWcFifUaBn6cXMGj6yS2J-Dcy7-tLtN4f6HSNfTrdU1vgCtVQyv0UmF0lWmlrnRFoZJCDUNTyqKUhjA6hOn2MPgOzliXuRZEfQT95uub3qOwbYqHlka_Sb184A
link.rule.ids 230,309,783,888,25578,76884
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFOebTsXp1ILSt-K2fqx9GNI1na32Y_SL7qmsJQNBuuEq_vteSqd72lvIwSW5cLmP5H4BeBoVDEZuiTswynNBUqgmaHS8EpgpHWgrRaE12LPrKVYsvaVy2oLPXS1MjRP6U4MjokYVqO9VfV5v_pNYpH5buX3OP7Br_TKLJoRvomM0T-gw82Q6Mec-8Q3eMCZxyHtBQ1OHA1HHWOkInWyVIe2byZTVpWz2jcrsDI7nyK-szqFFyy50jN3fa104cZsrb2w22re9gKEoWAsS-OnCT22P-I7JEYzDEj2yEzPk9JAzAisYcboX6a--Z4fRJTzOzMiwBBw7-1tqFof7ExWvoF2uS3oNXKFo41wtZCZXia6UpSrLVJSppo3lIi_EHvQPcbo5TH6AjhW5TubY3vstnDISSzMM1T60q69veoeGt8rva3n9Akytf9A
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=3-HYDROXYOXINDOLE+DERIVATIVES+AS+CRHR2+ANTAGONIST&rft.inventor=ANDO%2C+Kazuo&rft.inventor=MAGARA%2C+Ryohei&rft.inventor=OHMI%2C+Masashi&rft.date=2024-01-18&rft.externalDBID=A1&rft.externalDocID=US2024018103A1